Clinical Trials Directory

Trials / Completed

CompletedNCT02611076

Smoking-cessation: A Spanish-Language Clinical Trial

Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-Language Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to develop and test a series of culturally relevant and appropriate booklets in Spanish, designed to assist Hispanic smokers in quitting smoking and remaining smoke-free.

Detailed description

Study Aim 1: To transcreate the existing English-language 10 "Stop Smoking for Good" booklets and accompanying 9 supportive "My Story" pamphlets into a series of culturally relevant and acceptable materials for Spanish-speaking smokers who prefer to receive health information in Spanish. The adaptation of the intervention materials will be based upon the findings from a systematic formative evaluation employing a heterogeneous group of Hispanic/Latino smokers representing diverse subcultural groups. Study Aim 2: To test the efficacy of the self-help intervention developed in Study I among Spanish-speaking smokers in a randomized controlled trial. Participants (500) will be randomized to receive the Spanish-language version of the Stop Smoking for Good (SS-SP) intervention or usual care (UC) comprising an existing booklet from NCI. Investigators hypothesize SS-SP will produce higher abstinence rates than UC through 24 months. Secondary Aim: Test moderator variables to improve targeting the intervention. Moderator analyses will be exploratory, without strong a priori hypotheses.

Conditions

Interventions

TypeNameDescription
BEHAVIORALStop Smoking for Good Intervention in Spanish (SS-SP)Assessments will occur at six-month intervals, through 24 months.
BEHAVIORALUsual care (UC)Assessments will occur at six-month intervals, through 24 months.

Timeline

Start date
2015-10-15
Primary completion
2016-10-11
Completion
2021-10-28
First posted
2015-11-20
Last updated
2022-01-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02611076. Inclusion in this directory is not an endorsement.